Barbara Loftus

1.5k total citations
30 papers, 1.2k citations indexed

About

Barbara Loftus is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Barbara Loftus has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Barbara Loftus's work include Prostate Cancer Treatment and Research (5 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cancer-related Molecular Pathways (3 papers). Barbara Loftus is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cancer-related Molecular Pathways (3 papers). Barbara Loftus collaborates with scholars based in Ireland, United States and United Kingdom. Barbara Loftus's co-authors include Rob Michalides, Ellen Wientjens, A. J. M. Balm, P. Dervan, Desmond N. Carney, Johan Wennerberg, Michael Dictor, John Thornhill, Yuesheng Jin and Fredrik Mertens and has published in prestigious journals such as Cancer, Cancer Research and The Journal of Urology.

In The Last Decade

Barbara Loftus

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Loftus Ireland 17 608 527 269 244 219 30 1.2k
M Furihata Japan 19 526 0.9× 401 0.8× 326 1.2× 161 0.7× 130 0.6× 39 1.0k
Kyösti Nuorva Finland 22 340 0.6× 559 1.1× 259 1.0× 236 1.0× 489 2.2× 28 1.2k
Maria Oggionni Italy 12 523 0.9× 662 1.3× 252 0.9× 275 1.1× 497 2.3× 15 1.6k
Jens Packeisen Germany 18 749 1.2× 557 1.1× 206 0.8× 356 1.5× 106 0.5× 30 1.4k
Paola Casieri Italy 19 389 0.6× 624 1.2× 497 1.8× 212 0.9× 346 1.6× 43 1.5k
H Sakamoto Japan 18 1.0k 1.7× 434 0.8× 220 0.8× 211 0.9× 183 0.8× 32 1.5k
C. Fisher United Kingdom 12 351 0.6× 687 1.3× 221 0.8× 279 1.1× 158 0.7× 16 1.1k
Burke J. Brooks United States 15 665 1.1× 889 1.7× 668 2.5× 191 0.8× 79 0.4× 24 1.7k
Tooru Shiratori Japan 20 431 0.7× 519 1.0× 577 2.1× 129 0.5× 770 3.5× 36 1.7k
R. J. Cote United States 7 420 0.7× 669 1.3× 365 1.4× 645 2.6× 364 1.7× 9 1.4k

Countries citing papers authored by Barbara Loftus

Since Specialization
Citations

This map shows the geographic impact of Barbara Loftus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Loftus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Loftus more than expected).

Fields of papers citing papers by Barbara Loftus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Loftus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Loftus. The network helps show where Barbara Loftus may publish in the future.

Co-authorship network of co-authors of Barbara Loftus

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Loftus. A scholar is included among the top collaborators of Barbara Loftus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Loftus. Barbara Loftus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perry, Antoinette S., Gillian O’Hurley, Omer Raheem, et al.. (2012). Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer. International Journal of Cancer. 132(8). 1771–1780. 36 indexed citations
2.
Loftus, Barbara, et al.. (2012). The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens. International Urology and Nephrology. 44(6). 1705–1710. 12 indexed citations
3.
Foley, Robert W., Laure Marignol, Arun Z. Thomas, et al.. (2009). The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biology & Therapy. 8(2). 118–124. 45 indexed citations
4.
Hughes, Rosalind, Barbara Loftus, & Brian Kirby. (2009). Subacute cutaneous lupus erythematosus presenting as poikiloderma. Clinical and Experimental Dermatology. 34(8). e859–e861. 4 indexed citations
5.
O’Brien, Julie, Barbara Loftus, Ciara Barrett, & William C. Torreggiani. (2008). Leiomyoma of the testis: A rare testicular mass. Journal of Clinical Ultrasound. 36(4). 240–242. 8 indexed citations
6.
Murphy, Amanda J., Caroline Hughes, Ciara Barrett, et al.. (2007). Low-Level TOP2A Amplification in Prostate Cancer Is Associated with HER2 Duplication, Androgen Resistance, and Decreased Survival. Cancer Research. 67(6). 2893–2898. 36 indexed citations
7.
Perry, Antoinette S., Barbara Loftus, R Moroose, et al.. (2007). In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. British Journal of Cancer. 96(10). 1587–1594. 37 indexed citations
8.
Murphy, Amanda J., et al.. (2007). Heterogeneous expression of α‐methylacyl‐CoA racemase in prostatic cancer correlates with Gleason score. Histopathology. 50(2). 243–251. 19 indexed citations
9.
Cahill, Ronan A., Michael Jeffers, Barbara Loftus, et al.. (2006). Rapid assessment breast clinics – Evolution through audit. European Journal of Cancer. 42(17). 2961–2967. 7 indexed citations
10.
Hughes, Ciara, Anna V. Murphy, Cara Martin, et al.. (2006). Topoisomerase II-α expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma. Journal of Clinical Pathology. 59(7). 721–724. 23 indexed citations
11.
Murphy, Amanda J., et al.. (2005). Anaplastic Large Cell Lymphoma: A Unique Presentation with Urinary Bladder Involvement. International Journal of Surgical Pathology. 13(4). 369–374. 8 indexed citations
12.
Khan, Mohammad Saud, John Thornhill, Eoin F. Gaffney, Barbara Loftus, & Michael R. Butler. (2002). Keratinising Squamous Metaplasia of the Bladder: Natural History and Rationalization of Management Based on Review of 54 Years Experience. European Urology. 42(5). 469–474. 57 indexed citations
13.
Lanigan, D., et al.. (1994). A comparative analysis of grading systems in renal adenocarcinoma. Histopathology. 24(5). 473–476. 45 indexed citations
14.
Loftus, Barbara, et al.. (1994). KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 424(6). 635–40. 27 indexed citations
15.
Loftus, Barbara, Patrick J. Broe, Olwyn Johnston, & M. Leader. (1994). Primary amelanotic malignant melanoma of the oesophagus — A case report. Irish Journal of Medical Science (1971 -). 163(3). 128–131. 4 indexed citations
16.
Loftus, Barbara, et al.. (1992). Case report 759. Skeletal Radiology. 21(8). 538–41. 6 indexed citations
17.
Loftus, Barbara, et al.. (1991). Mac387: its non‐specificity as a tumour marker or marker of histiocytes. Histopathology. 19(3). 251–255. 24 indexed citations
19.
Loftus, Barbara, et al.. (1989). Are AgNORs useful in distinguishing follicular hyperplasia from follicular lymphoma?. Journal of Clinical Pathology. 42(12). 1267–1268. 16 indexed citations
20.
Loftus, Barbara & C. E. Connolly. (1988). Oestrogen receptor values and histologic type and grade in breast carcinoma — A three year review. Irish Journal of Medical Science (1971 -). 157(2). 49–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026